Literature DB >> 12488330

Regulation of oxytocin receptor expression in cultured human myometrial cells by fetal bovine serum and lysophospholipids.

Y-J Jeng1, S L Soloff, G D Anderson, M S Soloff.   

Abstract

Oxytocin receptor (OTR) expression in human myometrium increases over 150-fold from the beginning of pregnancy to the end. In the present studies, we examined potential mechanisms of OTR up-regulation, using myometrial cells in primary culture from women in late gestation. OTR ligand-binding sites and steady-state mRNA levels were down regulated by serum starvation, and up-regulated by restoration of fetal bovine serum (FBS). Transcriptional activity of the OTR gene was the same with or without FBS treatment, but FBS increased OTR mRNA half-life about 5-fold. Lysophospholipids (lysophosphatidic acid and sphingosine 1-phosphate), which are present in serum, had similar effects as FBS. Lysophospholipid receptor mRNAs of the endothelial differentiation gene (Edg) family (Edgs 1, 3, 4, and 5) were demonstrated in myometrial cells by RT-PCR. These G protein-coupled receptors have been shown to be coupled to G(i/o) and to mediate activation of phosphoinositol 3-phosphate kinase. Indeed, the effects of the lysophospholipids and FBS were completely blocked by pertussis toxin, a G(i/o) inhibitor. Likewise, inhibition of G(i/o) signaling by elevation of intracellular cAMP or inhibition of phosphoinositol 3-phosphate kinase blocked FBS effects on OTR mRNA stability. We do not presently understand the mechanisms of OTR up-regulation in human myometrium in vivo, but the present studies might lead to the description of mRNA-stabilizing factors whose activity can be quantified in tissue samples during pregnancy to elucidate the process of OTR up-regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12488330     DOI: 10.1210/en.2002-220636

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Effects of progesterone treatment on expression of genes involved in uterine quiescence.

Authors:  Melvyn S Soloff; Yow-Jiun Jeng; Michael G Izban; Mala Sinha; Bruce A Luxon; Susan J Stamnes; Sarah K England
Journal:  Reprod Sci       Date:  2011-08       Impact factor: 3.060

2.  Expression and activation of the oxytocin receptor in airway smooth muscle cells: Regulation by TNFalpha and IL-13.

Authors:  Yassine Amrani; Farhat Syed; Chris Huang; Katherine Li; Veronica Liu; Deepika Jain; Stefan Keslacy; Michael W Sims; Hasna Baidouri; Philip R Cooper; Hengjiang Zhao; Salman Siddiqui; Christopher E Brightling; Don Griswold; Lily Li; Reynold A Panettieri
Journal:  Respir Res       Date:  2010-07-29

3.  In vitro comparison of liposomal drug delivery systems targeting the oxytocin receptor: a potential novel treatment for obstetric complications.

Authors:  Susan Hua; Benjamin Vaughan
Journal:  Int J Nanomedicine       Date:  2019-03-27

Review 4.  Lysophosphatidic acid (LPA) signaling in human and ruminant reproductive tract.

Authors:  Izabela Wocławek-Potocka; Paulina Rawińska; Ilona Kowalczyk-Zieba; Dorota Boruszewska; Emilia Sinderewicz; Tomasz Waśniewski; Dariusz Jan Skarzynski
Journal:  Mediators Inflamm       Date:  2014-03-12       Impact factor: 4.711

Review 5.  Oxytocin in metabolic homeostasis: implications for obesity and diabetes management.

Authors:  C Ding; M K-S Leow; F Magkos
Journal:  Obes Rev       Date:  2018-09-25       Impact factor: 9.213

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.